© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Actinium Pharmaceuticals, Inc. (ATNM) shows an Average True Range (ATR) of 0.11 and an Enterprise Value of 132.97M. Its average trading volume over the past 3 months is 219.55K, indicating liquidity. These fundamental metrics provide insight into ATNM's underlying financial health and market activity.
Actinium Pharmaceuticals, Inc. (ATNM) technical indicators as of December 22, 2025: the SMA 20 is 15.48%, SMA 50 at 17.48%, and SMA 200 at 11.24%. The RSI 14 value is 64.7, suggesting its current momentum. These technical analysis signals help assess ATNM's price trends and potential future movements.
Actinium Pharmaceuticals, Inc. (ATNM) stock performance overview as of December 22, 2025: The 52-week high is $2.41 (currently -29.88% below), and the 52-week low is $1.03 (currently 64.21% above). Over the past year, ATNM's performance is 37.4%, compared to the S&P 500's 12.87% change.
According to market data, Actinium Pharmaceuticals, Inc. (ATNM) stock's recent performance metrics show that over the last month, ATNM is 18.18%, with a Year-to-Date (YTD) performance of 34.13%. Over the past year, the stock has seen a 37.4% change. These figures summarize ATNM's price movements across various periods, reflecting its historical returns.
According to current financial data, ATNM stock's P/E (TTM) ratio is -1.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ATNM, including P/S (58.58), P/B (3.82), and P/FCF (-2.11), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.